97102 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum Purification, fragmentation
METHODS TO PRODUCE A HUMAN PLASMA-DERIVED IGG PREPARATION ENRICHED IN BRAIN DISEASE-RELATED NATURAL IGGS
#2SUPRAMOLECULAR HIGH AFFINITY PROTEIN-BINDING SYSTEM FOR PURIFICATION OF BIOMACROMOLECULES
#3CHROMATOGRAPHY-FREE ANTIBODY PURIFICATION METHOD
#4Methods of Purifying Antibodies
#5PROCESS OF PURIFICATION OF PROTEIN
#6SYSTEMS AND METHODS FOR PREPARING A POLYPEPTIDE FROM A MIXTURE
#7AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN
#8AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN
#9METHOD TO IMPROVE VIRUS FILTRATION CAPACITY
#10PROCESS OF PURIFICATION OF PROTEIN
#11METHODS AND COMPOSITIONS COMPRISING PURIFIED RECOMBINANT POLYPEPTIDES
#12SEPARATION OF TRIPLE-LIGHT CHAIN ANTIBODIES USING CATION EXCHANGE CHROMATOGRAPHY
#13METHODS FOR INCREASING THE CAPACITY OF PURIFICATION PROCESSES
#14METHODS OF SEPARATING HOST CELL LIPASES FROM A PRODUCTION PROTEIN IN CHROMATOGRAPHIC PROCESSES
#15SYSTEMS AND METHODS FOR CHROMATOGRAPHY USE AND REGENERATION
#16AFFINITY CHROMATOGRAPHIC PRODUCTION OF CLINICAL HUMAN IGG PRODUCTS
#17Method of Antigen-Binding Protein Production
#18HYDROPHOBIC INTERACTION CHROMATOGRAPHY FOR VIRAL CLEARANCE
#19CHROMATOGRAPHY RESIN HAVING AN ANIONIC EXCHANGE-HYDROPHOBIC MIXED MODE LIGAND
#20ON-COLUMN VIRAL INACTIVATION METHODS
#21PEPTIDE ANTIGENS FOR FORMYLMETHIONINE ANTIBODY PRODUCTION
#22PROCESS OF AFFINITY CHROMATOGRAPHY
#23NOVEL ANTIGEN PEPTIDE FOR PREPARATION OF FORMYL-METHIONINE-SPECIFIC ANTIBODY
#24METHOD OF PURIFYING IMMUNOGLOBULIN G AND USES THEREOF
#25ALKALINE STABLE FC-BINDING PROTEINS FOR AFFINITY CHROMATOGRAPHY
#26High Efficiency Methods for Isolating Proteins
#27METHODS FOR THE PRODUCTION OF THERAPEUTIC, DIAGNOSTIC, OR RESEARCH ANTIBODIES
#28PROCESS OF PURIFICATION OF PROTEIN
#29TRANSGENIC MICE WITH HUMANIZED MHC I AND IMMUNOGLOBLUIN HEAVY CHAIN GENES
#30TRANSGENIC MICE WITH HUMANIZED MHC I AND IMMUNOGLOBLUIN HEAVY CHAIN GENES
#31METHOD FOR PRODUCING A LYOPHILIZED COMPOSITION COMPRISING POLYCLONAL IGM AND COMPOSITION OBTAINED
#32PROCESS FOR PREPARATION OF STABLE PROTEIN SOLUTION
#33Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof
#34ANTI-PNEUMOCOCCAL HYPERIMMUNE GLOBULIN FOR THE TREATMENT AND PREVENTION OF PNEUMOCOCCAL INFECTION
#35LARGE SCALE PURIFICATION OF ANTIBODIES
#36ION EXCHANGE MEMBRANE CHROMATOGRAPHY
#37Process of purification of protein
#38MULTISTEP FINAL FILTRATION
#39SYSTEMS AND METHODS FOR PREPARING A POLYPEPTIDE FROM A MIXTURE
#40PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING IMMUNE DYSREGULATION-RELATED DISEASES COMPRISING OXIDIZED IMMUNOGLOBULIN AS ACTIVE INGREDIENT
#41SYSTEMS AND METHODS FOR PROCESS SCALE ISOLATION OF A PROTEIN
#42Antibody Purification
#43PROCESS OF PURIFICATION OF PROTEIN
#44FAST PROTEIN SEQUENCING
#45MULTISTEP FINAL FILTRATION
#46FC-RECEPTOR BASED AFFINITY CHROMATOGRAPHY
#47REMOVAL OF SERINE PROTEASES BY TREATMENT WITH FINELY DIVIDED SILICON DIOXIDE
#48METHODS AND COMPOSITIONS COMPRISING AN ANTI-CTLA4 MONOCLONAL ANTIBODY WITH REDUCED HOST CELL PROTEINS AND INCREASED POLYSORBATE-80 STABILITY
#49LINKER PEPTIDE FOR CONSTRUCTING FUSION PROTEIN
#50SYSTEMS AND METHODS FOR PROCESS SCALE ISOLATION OF A PROTEIN
#51COMPONENTS FOR SEPARATING MOLECULES AND METHODS OF MAKING AND USING THE SAME
#52METHOD TO IMPROVE VIRUS FILTRATION CAPACITY
#53SUPRAMOLECULAR FILAMENTOUS ASSEMBLIES FOR PROTEIN PURIFICATION
#54POLYMER FOR PURIFICATION OF BIOMOLECULES
#55Affinity Chromatography Ligands with Mild Elution pH
#56METHOD FOR OBTAINING A COMPOSITION COMPRISING HUMAN PLASMA-DERIVED IMMUNOGLOBULIN M
#57A FILTRATION UNIT AND A METHOD FOR BIOMATERIAL PURIFICATION
#58METHODS OF INACTIVATING VIRAL CONTAMINANTS
#59COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF
#60METHODS FOR QUANTITATING INDIVIDUAL ANTIBODIES FROM A MIXTURE
#61ANTIBODIES
#62Separation Matrix
#63HYDROPHOBIC INTERACTION PROTEIN CHROMATOGRAPHY UNDER NO-SALT CONDITIONS
#64METHOD OF PURIFYING AN Fc-FUSION PROTEIN
#65Antibodies that Specifically Bind PD-1 and Methods of Use
#66PROCESS FOR PREPARATION OF STABLE PROTEIN SOLUTION
#67MUTATED IMMUNOGLOBULIN-BINDING POLYPEPTIDES
#68On-column viral inactivation methods
#69METHODS FOR DETECTING EARLY DAMAGE OF BLOOD-BRAIN BARRIER IN ISCHEMIC STROKE AND APPLICATION THEREOF
#70Protein for rapid, efficient capture of antigens
#71Separation matrix
#72Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand
#73Separation Method
#74Methods and compositions comprising purified recombinant polypeptides
#75MULTISPECIFIC BINDING PROTEINS AND METHODS OF DEVELOPING THE SAME
#76BIOPROCESS WITH REDUCED FOULING ON SURFACES
#77Treatment of severe community acquired pneumonia
#78LOW-VISCOSITY, HIGH CONCENTRATION EVOLOCUMAB FORMULATIONS AND METHODS OF MAKING THE SAME
#79Preparation and Purification of Hypersialylated IGG
#80AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN
#81AN IMPROVED PROCESS OF AFFINITY CHROMATOGRAPHY
#82AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN
#83CYCLOPHOSPHAMIDE ANALOGS FOR USE AS IMMUNOGENS AND ASSAY CONJUGATES FOR AN IMMUNOASSAY OF CYCLOPHOSPHAMIDE AND IFOSFAMIDE
#84A METHOD TO PRODUCE AN IMMUNOGLOBULIN PREPARATION FROM C-1 INHIBITOR DEPLETED PLASMA
#85METHOD FOR THE PRODUCTION AND PURIFICATION OF MULTIVALENT IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#86Hybridoma cell line of secreting cyproheptadine monoclonal antibodies and preparation method thereof
#87NON-PROTEIN A PURIFICATION METHOD FOR ADALIMUMAB
#88Methods for quantitating individual antibodies from a mixture
#89System and method for characterizing protein dimerization
#90METHODS OF SEPARATING HOST CELL LIPASES FROM AN ANTI-LAG3 ANTIBODY PRODUCTION
#91Process for concentration of antibodies and therapeutic products thereof
#92Method of Antigen-Binding Protein Production
#93SUPRAMOLECULAR HIGH AFFINITY PROTEIN-BINDING SYSTEM FOR PURIFICATION OF BIOMACROMOLECULES
#94METHODS TO DECREASE IMPURITIES FROM RECOMBINANT PROTEIN MANUFACTURING PROCESSES
#95DIRECT SELECTION OF CELLS EXPRESSING HIGH LEVELS OF HETEROMERIC PROTEINS USING GLUTAMINE SYNTHETASE INTRAGENIC COMPLEMENTATION VECTORS
#96METHODS FOR PURIFYING ANTIBODIES
#97NOVEL METHODS OF GENERATING ANTIBODIES
#98NOVEL IGFR-LIKE RECEPTOR AND USES THEREOF
#99CHARACTERIZATION OF PROTEINS BY ANION-EXCHANGE CHROMATOGRAPHY MASS SPECTROMETRY (AEX-MS)
#100MATE AND SEPARATE: A CONVENIENT AND GENERAL METHOD FOR THE SEPARATION AND PURIFICATION OF TARGET MOLECULES FROM BIOLOGICAL MEDIA BY PHASE TRANSITION OF PEGYLATED RECOGNITION AGENTS.
#101GLYCOFORM PURIFICATION
#102HIGH SALT LOAD CONDITIONING DURING CATION EXCHANGE CHROMATOGRAPHY TO REMOVE PRODUCT-RELATED IMPURITIES
#103Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof
#104ERENUMAB COMPOSITIONS AND USES THEREOF
#105Anti-galectin-9 antibodies and uses thereof
#106Isolation and purification of anti-IL-13 antibodies using protein a affinity chromatography
#107PURIFIED ANTIBODY COMPOSITION
#108ANTI-GALECTIN-9 ANTIBODIES AND USES THEREOF
#109SYSTEMS AND METHODS FOR EXCHANGE OF BUFFER SOLUTIONS
#110Virus filtration
#111METHOD FOR PURIFYING ANTIBODY USING ADSORBENT
#112METHODS FOR THE PURIFICATION OF PROTEINS USING CAPRYLIC ACID
#113Systems and methods for chromatography use and regeneration
#114Methods of Purifying Masked Antibodies
#115METHOD TO IMPROVE VIRUS FILTRATION CAPACITY
#116METHODS AND FORMULATIONS FOR REDUCING RECONSTITUTION TIME OF LYOPHILIZED POLYPEPTIDES
#117Methods for purifying antibodies
#118Process for Purifying Monoclocal Antibodies
#119COMPOSITIONS AND METHODS FOR THE DETECTION OF HOST CELL PROTEINS
#120Compositions and methods for the detection of host cell proteins
#121Human Immunoglobulin Against Methicillin-Resistant Staphylococcus Aureus, Preparation Method Therefor, And Use Thereof
#122METHODS OF SEPARATING HOST CELL LIPASES FROM A PRODUCTION PROTEIN IN CHROMATOGRAPHIC PROCESSES
#123ANTIBODY PURIFICATION METHODS AND COMPOSITIONS THEREOF
#124INNOVATIVE PRODUCTION TECHNIQUE FOR ANTIBODY-ENZYME
#125METHOD FOR PURIFYING DIGLYCOSYLATED INTERFERON-BETA PROTEIN
#126Compositions of programmed death receptor 1 (PD-1) antibodies and methods of obtaining the compositions thereof
#127PROCESSES FOR OBTAINING A HIGHLY CONCENTRATED ANTIBODY SOLUTION
#128IMMUNOGLOBULIN-BINDING PROTEIN AND AFFINITY SUPPORT USING SAME
#129Process for Preparing Immunoglobulin Compositions
#130Expression Process
#131Systems and methods for process scale isolation of immunoglobulin G
#132PROTEIN PURIFICATION METHOD
#133PROCESS FOR THE PURIFICATION OF RECOMBINANT POLYPEPTIDES
#134Methods of Engineering Surface Charge for Bispecific Antibody Production
#135SYSTEM AND METHOD FOR CHARACTERIZING DRUG PRODUCT IMPURITIES
#136METHOD TO PRODUCE A HIGHLY CONCENTRATED IMMUNOGLOBULIN PREPARATION FOR SUBCUTANEOUS USE
#137AFFINITY CHROMATOGRAPHY PURIFICATION WITH LOW CONDUCTIVITY WASH BUFFER
#138Method for the reduction of host cell proteins in affinity chromatography
#139Separation Matrix and a Method of Separating Antibodies
#140CONTINUOUS VIRUS RETENTIVE FILTRATION
#141Linker peptide for constructing fusion protein
#142METHODS FOR PURIFYING ANTIBODIES COMPRISING OF A PROCESS BY USING ACTIVATED CARBON MATERIALS
#143METHOD FOR TRANSFERRING A BATCH PRODUCTION PROCESS TO A CONTINUOUS PRODUCTION PROCESS
#144Crosslinked polysaccharide based absorbents for removal of anti-A and/or anti-B antibodies from human plasma and whole blood
#145Method for using light scattering in real time to directly monitor and control impurity removal in purification processes
#146Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
#147PEPTIDE LIGANDS FOR CAPTURE OF HOST CELL PROTEINS
#148METHOD TO PRODUCE AN IMMUNOGLOBULIN PREPARATION WITH IMPROVED YIELD
#149Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the same
#150Calibrator, complex, and method for measuring IgA aggregate
#151CHROMATOGRAPHY-FREE ANTIBODY PURIFICATION METHOD
#152METHOD FOR PREPARING PEPTIDE FRAGMENTS, METHOD FOR PREPARING PROTEASE TO BE USED THEREIN, AND KIT FOR PREPARING PEPTIDE FRAGMENTS
#153Methods of inactivating viral contaminants
#154Methods for the production of therapeutic, diagnostic, or research antibodies
#155IgG STIMULATED REMYELINATION OF PERIPHERAL NERVES
#156Methods for purifying antibodies
#157Methods for de novo protein sequencing
#158IMMUNOGLOBULIN CONSTANT REGION FC RECEPTOR BINDING AGENTS
#159Methods for quantitating individual antibodies from a mixture
#160PURIFIED ANTIBODY COMPOSITION
#161FC-REGION VARIANTS WITH MODIFIED FCRN- AND PROTEIN A-BINDING PROPERTIES
#162TREATMENT OF ALZHEIMER'S DISEASE SUBPOPULATIONS WITH POOLED IMMUNOGLOBULIN G
#163Separation matrix
#164Hydrophobic interaction chromatography for viral clearance
#165ALKALINE STABLE FC-BINDING PROTEINS FOR AFFINITY CHROMATOGRAPHY
#166Methods of treating viral infections by administering an antibody preparation comprising IGG, IGA and IGM
#167METHOD FOR PROTEIN PURIFICATION
#168Soluble HLA class II complexes and methods of production and uses thereof
#169Mutated Immunoglobulin-Binding Polypeptides
#170Treatment of severe community acquired pneumonia
#171Mutated immunoglobulin-binding polypeptides
#172Removal of serine proteases by treatment with finely divided silicon dioxide
#173METHOD FOR THE GENERATION OF A MULTIVALENT, MULTISPECIFIC ANTIBODY EXPRESSING CELLS BY TARGETED INTEGRATION OF MULTIPLE EXPRESSION CASSETTES IN A DEFINED ORGANIZATION
#174Methods for purifying antibodies having reduced high molecular weight aggregates
#175METHOD FOR PURIFYING PROTEINS
#176Methods of producing anti-C5 antibodies
#177Methods of purifying recombinant anti-abeta antibodies
#178Antibodies that specifically bind PD-1 and methods of use
#179PROCESS FOR CONCENTRATION OF ANTIBODIES AND THERAPEUTIC PRODUCTS THEREOF
#180Mutated immunoglobulin-binding polypeptides
#181Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand
#182METHODS TO PRODUCE A HUMAN PLASMA-DERIVED IGG PREPARATION ENRICHED IN BRAIN DISEASE-RELATED NATURAL IGGS
#183METHODS FOR PURIFYING RECOMBINANT POLYPEPTIDES
#184USE OF CAPRYLIC ACID PRECIPITATION FOR PROTEIN PURIFICATION
#185PROTEIN PURIFICATION PROCESS
#186Environmentally compatible detergents for inactivation of lipid-enveloped viruses
#187Methods for quantitating individual antibodies from a mixture
#188ANTIBODY FOR DETECTING EARLY DAMAGE OF BLOOD-BRAIN BARRIER IN ISCHEMIC STROKE AND APPLICATION THEREOF
#189Antibody Purification
#190Solid phase for mixed-mode chromatographic purification of proteins
#191Immunoglobulin purification
#192METHODS OF INACTIVATING VIRAL CONTAMINANTS
#193Hybridoma cell strain secreting nifursolol residue marker monoclonal antibody
#194Method to improve virus filtration capacity
#195Method for purification of immunoglobulin
#196DNA-binding domain of CRISPR system, non-fucosylated and partially fucosylated proteins, and methods thereof
#197System and method for characterizing protein dimerization
#198Separation matrix
#199Multistep final filtration
#200Identification and monitoring of immunoglobulin J chains
#201Separation method
#202On-column viral inactivation methods
#203Use of alkaline washes during chromatography to remove impurities
#204METHODS FOR PURIFYING ANTIBODIES
#205Methods for preventing disulfide bond reduction in cell culture harvest with selenite
#206Treatment of severe community acquired pneumonia
#207Systems and methods for exchange of buffer solutions
#208Method of storing a separation matrix
#209PROTEIN PURIFICATION METHOD
#210Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the same
#211ANTIBODY PURIFICATION AND PURITY MONITORING
#212IgG STIMULATED REMYELINATION OF PERIPHERAL NERVES
#213DETECTION OF CHO-MIF CONTAMINATIONS
#214IMMUNOGLOBULIN PURIFICATION
#215Supramolecular filamentous assemblies for protein purification
#216POLYVALENT IMMUNOTHERAPEUTICS OF HIGH SPECIFICTY BASED ON MODIFIED ANTIBODIES AND A LYOPHILIZED INJECTABLE FORMULATION HIGHLY SAFE AND EFFECTIVE
#217OPTIMIZED METHOD FOR ANTIBODY CAPTURING BY MIXED MODE CHROMATOGRAPHY
#218Method for purifying anti-IL-6 receptor antibodies
#219Immunoglobulin compositions and process for obtaining the same
#220Control of trace metals during production of anti-CD38 antibodies
#221Anti-PD-L1 nanobody, coding sequence and use thereof
#222COMPUTATIONAL AFFINITY MATURATION OF ANTIBODY LIBRARIES USING SEQUENCE ENUMERATION
#223Fast protein sequencing
#224Methods of purifying antibodies
#225Ion exchange membrane chromatography
#226High-throughput immune sequencing
#227Process for the purification of recombinant antibody fragments
#228MUTATED IMMUNOGLOBULIN-BINDING POLYPEPTIDES
#229Separation matrix
#230Stabilized antibody protein solutions
#231Salt tolerant anion exchange medium
#232Method for removing anti-AAV antibodies from a blood-derived composition
#233Supramolecular high affinity protein-binding system for purification of biomacromolecules
#234Proteolytic inactivation of select proteins in bacterial extracts for improved expression
#235Methods for de novo protein sequencing
#236Antibody preparation
#237Hybridoma cell strain secreting nifursolol residue marker monoclonal antibody
#238Production of immunotoxin D2C7—(scdsFv)—PE38KDEL
#239PROCESS OF CLONING AND FURTHER PURIFICATION TO MAKE A RECOMBINANT INTRAVENOUS IMMUNOGLOBULIN
#240Method for using light scattering in real time to directly monitor and control impurity removal in purification processes
#241AFFINITY SEPARATION MATRIX FOR PURIFYING IMMUNOGLOBULIN
#242Cyclophosphamide analogs for use as immunogens and assay conjugates for an immunoassay of cyclophosphamide and ifosfamide
#243Anti-galectin-9 antibodies and uses thereof
#244High throughput interrogation of physiochemical properties of a protein
#245Systems and methods for preparing a polypeptide from a mixture
#246Methods and formulations for reducing reconstitution time of lyophilized polypeptides
#247VHH antibody
#248Affinity chromatography ligands with mild elution pH
#249HIGH THROUGHPUT ANTIBODY VARIANT SCREENING METHOD
#250METHOD FOR PURIFYING ANTIBODY
#251Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof
#252IL-13 antibody and preparation method and use thereof
#253Erenumab compositions and uses thereof
#254Alkaline stable Fc-binding proteins for affinity chromatography
#255Purified antibody composition
#256GENETICALLY MODIFIED NON-HUMAN ANIMALS FOR GENERATING THERAPEUTIC ANTIBODIES AGAINST PEPTIDE-MHC COMPLEXES, METHODS OF MAKING AND USES THEREOF
#257METHODS OF INACTIVATING VIRAL CONTAMINANTS
#258Hybridoma cell line of secreting clarithromycin monoclonal antibodies and preparation method thereof
#259Hybridoma cell line that secrets cyproheptadine monoclonal antibodies and preparation method thereof
#260Fc-receptor based affinity chromatography
#261Anti-PD-1 antibodies and methods of treatment
#262PROTEIN CAPABLE OF BINDING SPECIFICALLY TO IMMUNOGLOBULIN, AND IMMUNOGLOBULIN-BINDING AFFINITY LIGAND
#263Anti-galectin-9 antibodies and uses thereof
#264Process for preparation of secretory IgA and secretory IgM
#265AFFINITY LIGANDS AND METHODS RELATING THERETO
#266System and method for characterizing protein dimerization
#267Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
#268Chromatography method
#269SYSTEM AND METHOD FOR CHARACTERIZING DRUG PRODUCT IMPURITIES
#270METHOD OF MANUFACTURING PROTHROMBIN COMPLEX CONCENTRATE FROM FRACTION III AND NON-PROTHROMBIN COMPLEX CONCENTRATE FROM FRACTION IV
#271Recombinant FcγRII
#272Method for producing antibody fusion protein
#273Immunoglobulin constant region Fc receptor binding agents
#274Method for purifying antibody or antibody fragment containing κ-chain variable region
#275Fc-binding protein, method for producing said protein, antibody adsorbent using said protein, and method for separating antibody using said adsorbent
#276METHOD FOR PURIFYING PROTEIN USING ACTIVATED CARBON
#277PARTICLE SETTING DEVICES
#278ANTIGEN BIOMARKERS
#279PURIFICATION OF ANTI-C-MET ANTIBODIES
#280Cyclic peptide, affinity chromatography support, labeled antibody, antibody drug conjugate, and pharmaceutical preparation
#281IMPROVED PHARMACOKINETIC ASSAYS FOR IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#282Antibody or an antigen-binding fragment thereof capable of binding to a human receptor of interleukin-6
#283Polypeptide exhibiting affinity to antibodies forming non-native three-dimensional structure
#284ANTIVIRAL POLYCLONAL ANTIBODIES AGAINST EBOLA VIRUS AND THE USES THEREOF
#285Methods for quantitating individual antibodies from a mixture
#286Linker peptide for constructing fusion protein
#287Antibody targeted to tissue factor, preparation method therefor, and use thereof
#288Anti-PD-L1 nanobody, coding sequence and use thereof
#289CELL CULTURE ADDITIVES AND THEIR USE FOR INCREASED BIOPROTEIN PRODUCTION FROM CELLS
#290Alkaline stable immunoglobulin-binding proteins
#291Removal of serine proteases by treatment with finely divided silicon dioxide
#292Process for preparing immunoglobulin compositions
#293Antibody binding nanofibrils
#294METHOD FOR PRODUCING ANTIBODY FRAGMENT
#295Methods for increasing the capacity of purification processes
#296Methods for purification of single domain antigen binding molecules
#297TREATMENT OF ALZHEIMER'S DISEASE SUBPOPULATIONS WITH POOLED IMMUNOGLOBULIN G
#298Hydrophobic interaction protein chromatography under no-salt conditions
#299Method for suppressing aggregation of polypeptide
#300Compositions and methods for the detection of host cell proteins